Biosurgery Market By Product Type (Anti Adhesive Agents, Bone Graft Substitutes, Hemostatic And Surgical Sealant, Mesh), By Application (Cardiovascular And Thoracic Surgery, Neuro And Spine Surgery, Orthopedic Surgery, General Surgery), By Source (Biologics Products, Synthetic Products): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global Biosurgery market was valued at $11,425.5 million in 2020, and is projected to reach $27,324.8 million by 2030, registering a CAGR of 9.1% from 2021 to 2030.
Biosurgery products consist of synthetic, semisynthetic or natural material that help in tissue repair and seal surgical incision. Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Biosurgery products also help facilitate tissue sealing hemostasis. Moreover, biosurgery products are used in hard tissue regeneration in ortho-biologics. Various synthetic and biologic products, such as anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for prevention of excessive blood loss or providing adhesion or wound/tissue sealing.
The growth of the global biosurgery market is majorly driven by increase in prevalence of chronic disease, trauma, rise in government and private organizations initiatives for development of the medical devices sector, surge in number of surgical procedures, and rise in demand for biosurgery products.
Furthermore, rise in number of geriatric population drives the growth of the market. This is attributed to the fact that geriatric population is highly vulnerable to chronic diseases, which boosts the need for various surgical procedure and upsurge the demand for biosurgery products. This factor is expected to notably contribute toward the growth of the global biosurgery market.
In addition, increase in sports-related injuries and surgeries, increase in sedentary lifestyle, and rise in several approvals for biosurgery, drive the growth of the global biosurgery market.
In addition, increase in R&D activities in the healthcare industry and rise in blood loss management systems are anticipated to provide lucrative opportunities for the market expansion.
However, high cost of biosurgery products and stringent government regulations hinder the market growth. On the contrary, increase in awareness among physicians and researchers about the use of biosurgery products augments the growth of the biosurgery market. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the biosurgery market.
The biosurgery market is segmented on the basis of product type, application, source, and region. Depending on the product type, the market is divided into anti-adhesive agents, hemostatic agents and surgical sealants, bone graft substitutes, and mesh (soft tissue management). On the basis of application, the market is segmented into cardiovascular and thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. On the basis of source, the market is segmented into biologics products, and synthetic products. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biosurgery market are Aroa Biosurgery Limited, B. Braun Melsungen AG, Baxter International Inc., BD (Becton, Dickinson and Company), Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., Tissue Regenix Groups.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biosurgery market analysis from 2020 to 2030 to identify the prevailing biosurgery market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the biosurgery market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global biosurgery market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Anti Adhesive Agents
Bone Graft Substitutes
Hemostatic And Surgical Sealant
Cardiovascular And Thoracic Surgery
Neuro And Spine Surgery
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
Key Market Players
aroa biosurgery limited
Baxter International Inc.
B. BRAUN MELSUNGEN AG
Becton, Dickinson and Company
INTEGRA LIFE SCIENCES HOLDINGS CORP
JOHNSON and JOHNSON SERVICES, INC.
SANOFI S A
TISSUE REGENIX GROUP
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook